Paper1969115
Zidovudine in asymptomatic human immunodeficiency virus infection. A controlled trial in persons with fewer than 500 CD4-positive cells per cubic millimeter. The AIDS Clinical Trials Group of the National Institute of Allergy and Infectious Diseases.
Volberding PA and 9 others. N Engl J Med, 1990. Cited by 1,272 papers, by iCite.
Cite this record
ConductScience Library. Zidovudine in asymptomatic human immunodeficiency virus infection. A controlled trial in persons with fewer than 500 CD4-positive cells per cubic millimeter. The AIDS Clinical Trials Group of the National Institute of Allergy and Infectious Diseases. Papers, record 1969115. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/1969115
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
Zidovudine in asymptomatic human immunodeficiency virus infection. A controlled trial in persons with fewer than 500 CD4-positive cells per cubic millimeter. The AIDS Clinical Trials Group of the National Institute of Allergy and Infectious Diseases.
- PubMed
Topics19
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| CD4-Positive T-Lymphocytes | Major topic |
| HIV Infections | Major topic |
| Zidovudine | Major topic |
| AIDS-Related Complex | |
| Acquired Immunodeficiency Syndrome | |
| Adult | |
| Double-Blind Method | |
| Female | |
| Follow-Up Studies | |
| Gene Products, gag | |
| HIV Antigens | |
| HIV Core Protein p24 | |
| Humans | |
| Leukocyte Count | |
| Male | |
| Middle Aged | |
| Patient Acceptance of Health Care | |
| Randomized Controlled Trials as Topic | |
| Viral Core Proteins |
Source PubMed
Trials1
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
| Trial | Title | The trial lists it as | Named in the paper's record |
|---|---|---|---|
| NCT00000736 | Safety and Efficacy of Zidovudine for Asymptomatic HIV-Infected Individuals | Background |
Source ClinicalTrials.gov
Comments and corrections2
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
| Kind | PMID | Title | In Papers | Source |
|---|---|---|---|---|
| Comment in | 1969114 | Early treatment for HIV: the time has come. | https://conductscience.org/library/papers/1969114 | PubMed |
| Comment in | 2388674 | Zidovudine in asymptomatic HIV infection. | https://conductscience.org/library/papers/2388674 | PubMed |
Cited by201
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 1,272 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42338362 | Rejoinder to Commentaries on "A Perspective on the Appropriate Implementation of ICH E9(R1) Addendum Strategies for Handling Intercurrent Events". | Stat Med | 2026 | https://conductscience.org/library/papers/42338362 | PubMed |
| 42166427 | Artificial intelligence in drug research and development: a review of methods and applications in drug repurposing. | Brief Bioinform | 2026 | https://conductscience.org/library/papers/42166427 | PubMed |
| 41849780 | Compressing Chemistry Reveals Functional Groups. | J Chem Inf Model | 2026 | https://conductscience.org/library/papers/41849780 | PubMed |
| 41369562 | Drug susceptibility of a clinical isolate of Balamuthia mandrillaris, a pathogenic free-living amoeba. | Antimicrob Agents Chemother | 2026 | https://conductscience.org/library/papers/41369562 | PubMed |
| 41013430 | Survival of kidney transplantation in people living with HIV/AIDS: a systematic review and meta-analysis. | BMC Infect Dis | 2025 | https://conductscience.org/library/papers/41013430 | PubMed |
| 39835565 | Drug Repurposing: A Conduit to Unravelling Metabolic Reprogramming for Cancer Treatment. | Mini Rev Med Chem | 2025 | https://conductscience.org/library/papers/39835565 | PubMed |
| 35229232 | It was 40 Years Ago Today: AIDS and the Brain. | Neurocrit Care | 2022 | https://conductscience.org/library/papers/35229232 | PubMed |
| 28369768 | Drug repurposing from the perspective of pharmaceutical companies. | Br J Pharmacol | 2018 | https://conductscience.org/library/papers/28369768 | PubMed |
| 27704821 | Discovery and Development of the Anti-Human Immunodeficiency Virus Drug, Emtricitabine (Emtriva, FTC). | Acc Chem Res | 2016 | https://conductscience.org/library/papers/27704821 | PubMed |
| 27182452 | A Brief Chronicle of CD4 as a Biomarker for HIV/AIDS: A Tribute to the Memory of John L. Fahey. | For Immunopathol Dis Therap | 2015 | https://conductscience.org/library/papers/27182452 | PubMed |
| 24192332 | Maternal anaemia and duration of zidovudine in antiretroviral regimens for preventing mother-to-child transmission: a randomized trial in three African countries. | BMC Infect Dis | 2013 | https://conductscience.org/library/papers/24192332 | PubMed |
| 23921730 | Trials challenging HIV drug doses could usher in huge cost cuts. | Nat Med | 2013 | https://conductscience.org/library/papers/23921730 | PubMed |
| 23877688 | Population pharmacokinetics study of recommended zidovudine doses in HIV-1-infected children. | Antimicrob Agents Chemother | 2013 | https://conductscience.org/library/papers/23877688 | PubMed |
| 23264786 | Prevalence, severity, and related factors of anemia in HIV/AIDS patients. | J Res Med Sci | 2012 | https://conductscience.org/library/papers/23264786 | PubMed |
| 22855396 | Daily quality control in CD3+ and CD4+ T cell estimation by the FACSCount system at a tertiary care center in south India. | Clin Vaccine Immunol | 2012 | https://conductscience.org/library/papers/22855396 | PubMed |
| 22451746 | Clinical significance and characterization of AZT-resistant strains of HIV-1. | Can J Infect Dis | 1991 | https://conductscience.org/library/papers/22451746 | PubMed |
| 21308456 | When to start antiretroviral therapy. | Curr Infect Dis Rep | 2011 | https://conductscience.org/library/papers/21308456 | PubMed |
| 21222041 | Statistical decisions and the interim analyses of clinical trials. | Theor Med Bioeth | 2011 | https://conductscience.org/library/papers/21222041 | PubMed |
| 21221397 | Early Clinical Signs and Symptoms of HIV Infection: Delaying progression to AIDS. | Can Fam Physician | 1992 | https://conductscience.org/library/papers/21221397 | PubMed |
| 21047391 | Baseline severe anaemia should not preclude use of zidovudine in antiretroviral-eligible patients in resource-limited settings. | J Int AIDS Soc | 2010 | https://conductscience.org/library/papers/21047391 | PubMed |
Genes2
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| CD4 | 920 | PubTator's text mining | https://conductscience.org/library/genes/920 | NCBI Gene |
| TMED2 | 10959 | PubTator's text mining | https://conductscience.org/library/genes/10959 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/1969115
GET https://conductscience.org/api/papers/v1/1969115/cited_by?page=2